These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 18841031)
1. A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines. Vici P; Di Lauro L; Sergi D; Foggi P; Viola G; Mottolese M; Giotta F; Fattoruso SI; Corsetti S; Giannarelli D; Botti C; Lopez M Oncology; 2008; 75(3-4):175-81. PubMed ID: 18841031 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer. Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034 [TBL] [Abstract][Full Text] [Related]
4. Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer. Wardley AM; Pivot X; Morales-Vasquez F; Zetina LM; de Fátima Dias Gaui M; Reyes DO; Jassem J; Barton C; Button P; Hersberger V; Torres AA J Clin Oncol; 2010 Feb; 28(6):976-83. PubMed ID: 20038734 [TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic breast cancer with vinorelbine and docetaxel. Savio G; Laudani A; Leonardi V; Pepe A; Scianna C; Gebbia V; Agostara B Am J Clin Oncol; 2006 Jun; 29(3):276-80. PubMed ID: 16755181 [TBL] [Abstract][Full Text] [Related]
6. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer. Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer. Infante JR; Yardley DA; Burris HA; Greco FA; Farley CP; Webb C; Spigel DR; Hainsworth JD Clin Breast Cancer; 2009 Feb; 9(1):23-8. PubMed ID: 19299236 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer. Campone M; Blasinska-Morawiec M; Tekiela A; Koralewski P; Pouget JC; Douville I; Brandely M Cancer Chemother Pharmacol; 2009 Apr; 63(5):937-43. PubMed ID: 18751706 [TBL] [Abstract][Full Text] [Related]
9. A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer. Shamseddine AI; Otrock ZK; Khalifeh MJ; Yassine HR; Charafeddine M; Abdel-Khalek Z; Chehal A; Bitar N; Jalloul R; Dheiny M; Dandashi A; Wehbeh M; El-Saghir NS Oncology; 2006; 70(5):330-8. PubMed ID: 17164589 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial. Park SH; Cho EK; Bang SM; Shin DB; Lee JH; Lee YD BMC Cancer; 2005 Feb; 5():21. PubMed ID: 15723709 [TBL] [Abstract][Full Text] [Related]
11. Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial. De Maio E; Pacilio C; Gravina A; Morabito A; Di Rella F; Labonia V; Landi G; Nuzzo F; Rossi E; Silvestro P; Botti G; Di Bonito M; Curcio MP; Formichelli F; La Vecchia F; Staiano M; Maurea N; D'Aiuto G; D'Aiuto M; Thomas R; Signoriello G; Perrone F; de Matteis A BMC Cancer; 2007 Mar; 7():50. PubMed ID: 17374151 [TBL] [Abstract][Full Text] [Related]
12. A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines. Campone M; Dobrovolskaya N; Tjulandin S; Chen SC; Fourie S; Mefti F; Konstantinova M; Lefresne F; Meheust N; Jassem J Breast J; 2013; 19(3):240-9. PubMed ID: 23528159 [TBL] [Abstract][Full Text] [Related]
13. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment. Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438 [TBL] [Abstract][Full Text] [Related]
14. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines. Pieńkowski T; Jagiello-Gruszfeld A Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes. Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients. Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898 [TBL] [Abstract][Full Text] [Related]
17. First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study. Pectasides D; Dimopoulos MA; Aravantinos G; Kalophonos HP; Papacostas P; Briasoulis E; Cogas E; Papadimitriou C; Skarlos D; Kosmidis P; Fountzilas G Anticancer Res; 2001; 21(5):3575-80. PubMed ID: 11848526 [TBL] [Abstract][Full Text] [Related]
18. Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study. Brugnatelli S; Riccardi A; Danova M; Pugliese P; Tinelli C; Luchena G; Bernardo A; Giardina G; Fava S; Montanari G; Pedrotti C; Poli AM Oncol Rep; 2001; 8(4):801-5. PubMed ID: 11410787 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer. Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D J Clin Oncol; 2007 Apr; 25(10):1232-8. PubMed ID: 17296975 [TBL] [Abstract][Full Text] [Related]
20. Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study. Polyzos A; Tsavaris N; Kosmas C; Gogas H; Toufexi H; Kosmidis C; Markopoulos C; Giannopoulos A; Papadopoulos O; Stamatiadis D; Kouraklis G J Chemother; 2003 Dec; 15(6):607-12. PubMed ID: 14998089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]